These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38752346)

  • 41. Why a randomized melanoma screening trial is not a good idea.
    Halvorsen JA; Løberg M; Gjersvik P; Roscher I; Veierød MB; Robsahm TE; Nilsen LTN; Kalager M; Bretthauer M
    Br J Dermatol; 2018 Aug; 179(2):532-533. PubMed ID: 29893490
    [No Abstract]   [Full Text] [Related]  

  • 42. Melanoma Diagnoses Rise While Mortality Stays Fairly Flat, Raising Concerns About Overdiagnosis.
    Rubin R
    JAMA; 2020 Apr; 323(15):1429-1430. PubMed ID: 32236494
    [No Abstract]   [Full Text] [Related]  

  • 43. Response to CME article "Screening, early detection, education, and trends for melanoma: current status (2007-2013) and future directions. Part I. Epidemiology, high-risk groups, clinical strategies, and diagnostic technology".
    Winkelmann RR; Rigel DS
    J Am Acad Dermatol; 2015 Apr; 72(4):745-7. PubMed ID: 25773423
    [No Abstract]   [Full Text] [Related]  

  • 44. Dermoscopy in skin self-examination: A useful tool for select patients.
    Goulart JM; Malvehy J; Puig S; Martin G; Marghoob AA
    Arch Dermatol; 2011 Jan; 147(1):53-8. PubMed ID: 21242394
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Melanoma in childhood: changing our mind-set.
    Silverberg NB; McCuaig CC
    Cutis; 2013 Nov; 92(5):217-8. PubMed ID: 24343205
    [No Abstract]   [Full Text] [Related]  

  • 46. Childhood melanoma: what every pediatrician should know.
    Dinulos J
    Curr Opin Pediatr; 2009 Aug; 21(4):472-4. PubMed ID: 19617832
    [No Abstract]   [Full Text] [Related]  

  • 47. A whole population analysis of sex-specific anatomic differences in melanoma: rising melanoma in situ on the legs and trunk in females.
    Hoyt DW; Thomas SI; Ahmed A; Kristjansson AK; Grant-Kels JM; Ungar JP; Jonasson JG; Adalsteinsson JA
    Arch Dermatol Res; 2024 Jun; 316(7):384. PubMed ID: 38864920
    [No Abstract]   [Full Text] [Related]  

  • 48. Incidence of cutaneous malignant melanoma in Denmark, 1978-2007.
    Fuglede NB; Brinck-Claussen UØ; Deltour I; Boesen EH; Dalton SO; Johansen C
    Br J Dermatol; 2011 Aug; 165(2):349-53. PubMed ID: 21466535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Epidemiological signatures and surveillance bias in cancer].
    Tancredi S; van der Linden B; Rosella L; Chiolero A
    Rev Med Suisse; 2024 Jul; 20(881):1298-1302. PubMed ID: 38961780
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Melanoma incidence and patient compliance in a targeted melanoma screening intervention. One-year follow-up in a large French cohort of high-risk patients.
    Rat C; Quereux G; Grimault C; Gaultier A; Khammari A; Dreno B; Nguyen JM
    Eur J Gen Pract; 2015 Jun; 21(2):124-30. PubMed ID: 25141184
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estimating Overdiagnosis of Melanoma Using Trends Among Black and White Patients in the US.
    Adamson AS; Suarez EA; Welch HG
    JAMA Dermatol; 2022 Apr; 158(4):426-431. PubMed ID: 35293957
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Not Available].
    de la Brière A; Warnet S
    Rev Infirm; 2016 Mar; (219):15. PubMed ID: 26944638
    [No Abstract]   [Full Text] [Related]  

  • 53. [Rapid increase in incidence of melanoma in situ in Girona (Spain), 1994-2005. Effectiveness of public education campaigns about early diagnosis].
    Vilar-Coromina N; Vilar-Coromina N; Vilardell L; Cano A; Marcos-Gragera R; Marcos-Gragera R
    Actas Dermosifiliogr; 2010 Jul; 101(6):561-3. PubMed ID: 20738982
    [No Abstract]   [Full Text] [Related]  

  • 54. Five-Year Outcomes of a Melanoma Screening Initiative in a Large Health Care System.
    Matsumoto M; Wack S; Weinstock MA; Geller A; Wang H; Solano FX; Kirkwood JM; Ferris LK
    JAMA Dermatol; 2022 May; 158(5):504-512. PubMed ID: 35385051
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnosis and management of melanoma in a rural general practice.
    Townsend T
    J Prim Health Care; 2018 Oct; 10(3):207-209. PubMed ID: 31039934
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Malignant melanoma. Epidemiology, screening, diagnosis, evolution, prognostic clinical and histopathologic criteria].
    Roudier-Pujol C; Saiag P
    Rev Prat; 1998 Oct; 48(15):1729-35. PubMed ID: 9814078
    [No Abstract]   [Full Text] [Related]  

  • 57. Increasing time trends of thin melanomas in The Netherlands: What are the explanations of recent accelerations?
    van der Leest RJ; Zoutendijk J; Nijsten T; Mooi WJ; van der Rhee JI; de Vries E; Hollestein LM
    Eur J Cancer; 2015 Dec; 51(18):2833-41. PubMed ID: 26589973
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Screening for Acral Lentiginous Melanoma in Dark-Skinned Individuals.
    Marchetti MA; Chung E; Halpern AC
    JAMA Dermatol; 2015 Oct; 151(10):1055-6. PubMed ID: 26083954
    [No Abstract]   [Full Text] [Related]  

  • 59. The ever-evolving landscape for detection of early melanoma: challenges and promises.
    Geller AC; Halpern AC
    J Invest Dermatol; 2013 Mar; 133(3):583-585. PubMed ID: 23399817
    [No Abstract]   [Full Text] [Related]  

  • 60. [New factors in the clinical aspect of malignant cutaneous melanoma].
    Spitalier JM; Amalric R; Ayme Y; Lieutaud R
    Bull Cancer; 1970; 57(4):403-11. PubMed ID: 4996813
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.